Business & Regulation

Pathways designed to bring medicines to market faster in Europe are not delivering the goods

What is an endolysin? We spoke with Bjorn Herpers from the Regional Public Health Laboratory Kennemerland, Haarlem, in the Netherlands to find out.

Sitting Down With… William Chin, Executive Vice President, Scientific and Regulatory Affairs, Pharmaceutical Research and Manufacturers of America (PhRMA).

Science and business: tenacious partners in a shaky marriage or eternally bound nonidentical twins?

How to use a knowledge repository that doesn’t retire or leave you for a competitor.

Will FDA fast review and voucher incentives make a difference?

Amgen accuses Sandoz of snubbing its advances in a complex biosimilar dispute

Can phage endolysins revolutionize the way bacterial infections are treated – and prevent drug resistance?

The 2014 Access to Medicine index shows progress – but companies remain “conservative”

The Ebola media frenzy has reminded the public how selfish our industry is. But, somehow, that doesn’t sound quite right...